Understanding EMPA-REG OUTCOME

Slides:



Advertisements
Similar presentations
How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.
Pharmacogenetics and future drug development and delivery
EMPA-REG OUTCOME: The Endocrinologist's Point of View
EMPA-REG OUTCOME: The Endocrinologist's Point of View
Thank God for Richard Dawkins?
Gian Paolo Fadini, Angelo Avogaro  The Lancet Diabetes & Endocrinology 
Understanding EMPA-REG OUTCOME
Punishment beatings and the rule of law
Author gender in The Lancet journals
EMPA-REG OUTCOME: The Endocrinologist's Point of View
Introduction The American Journal of Medicine
Understanding EMPA-REG OUTCOME
“Seeing” the Invisibles at the Single-Molecule Level
Physical activity and prevention of type 2 diabetes
Insulin affordability
Dental Extractions Using Improvised Equipment
Increased body-mass index in patients with narcolepsy
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Expanding perception through the disordered brain
Gordon G. Giesbrecht, PhD  Wilderness & Environmental Medicine 
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Non-uraemic calciphylaxis with acral necrosis
The Gobi Desert medical kit
The brain hallucinates and gets caught in the web
Physiological hazards of flight at high altitude
Can famine relief meet health and hunger goals simultaneously?
Punishment beatings and the rule of law
Structure of grepafloxacin relative to activity and safety profile
Organisation of the care of patients with heart failure
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK  Krishnan Bhaskaran, PhD,
HIV myths should not be resuscitated
Michael J Goldacre, Jenny J Maisonneuve  The Lancet 
Bruce Neal, Fiona Turnbull  The Lancet 
Volume 362, Pages s6-s7 (December 2003)
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.
Dental Extractions Using Improvised Equipment
Tribute to Jonna Barry Wilderness & Environmental Medicine
O. Larsell  Wilderness & Environmental Medicine 
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Telling it like it isn't: truth and lies in a post-9/11 world
Iran, sanctions, and collaborations
Thank God for Richard Dawkins?
Seeking asylum, losing hope
Low-technology approaches
The future of medical journals in the western world
Genital herpes—how much of a public-health problem?
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
C.P. Kelly  Clinical Microbiology and Infection 
Society for Investigative Dermatology 2010 Meeting Minutes
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28.
Gordon G. Giesbrecht, PhD  Wilderness & Environmental Medicine 
Research Snippets Journal of Investigative Dermatology
Reviewer Acknowledgment
Stephen Allison, Tarun Bastiampillai, Doris A Fuller 
Jiayue Hu, George Fu Gao, Ji-Long Chen  The Lancet 
A remarkable report card on progress in COPD
Jean H Humphrey, Andrew J Prendergast  The Lancet Global Health 
Robert H. Eckel, MD, Michael J. Blaha, MD, MPH 
Diabetic ketoacidosis and hyperosmolar crisis in adults
Guidance on research integrity: no union in Europe
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Volume 349, Issue 9062, Pages (May 1997)
Figure 1 ABCDE of primary prevention.2
Autism, maths, and sex: the special triangle
Reversible biological adaptations in obesity
Presentation transcript:

Understanding EMPA-REG OUTCOME Richard E Gilbert, Kim A Connelly  The Lancet Diabetes & Endocrinology  Volume 3, Issue 12, Pages 930-931 (December 2015) DOI: 10.1016/S2213-8587(15)00427-1 Copyright © 2015 Elsevier Ltd Terms and Conditions

Figure Time to heart failure events in the RECORD (left) and EMPA-REG OUTCOME (right) studies Adapted and reproduced from European Heart Journal (upper panel)3 and New England Journal of Medicine (lower panel),4 by permission of Oxford University Press and Massachusetts Medical Society, respectively. HR=hazard ratio. The Lancet Diabetes & Endocrinology 2015 3, 930-931DOI: (10.1016/S2213-8587(15)00427-1) Copyright © 2015 Elsevier Ltd Terms and Conditions